Magic Knight
Hybrid cannabis strain with disputed origins and moderate THC levels.
Magic Knight is a minor hybrid strain with no published clinical research specific to it. Like most cannabis strains, its effects are reported anecdotally by users—expect variation between individuals. Lineage claims are unclear and unverified. The 'magic' in the name is marketing; the actual cannabinoid and terpene profile, if consistent, determines effects more reliably than strain name folklore.
Overview
Magic Knight is a hybrid cannabis strain with minimal published documentation and no peer-reviewed research. It circulates primarily in online cannabis communities and seed banks, but its genetic origin, breeding history, and consistency across different growers remain unverified Weak / limited.
The strain has not been analyzed in controlled laboratory settings or registered with any major genetic database. Like most minor or newer strains, information about Magic Knight is sourced from grower reports, seed vendors, and user forums rather than scientific study. This means yield claims, flowering times, and cannabinoid profiles may vary significantly depending on cultivation conditions, breeder, and phenotype Anecdote.
Genetics & Lineage
The parentage of Magic Knight is disputed and unconfirmed Disputed. Some breeders claim it is a cross between [strain name] and [strain name], but these claims lack documentary evidence or verification by independent parties. Without verifiable breeding records or genetic sequencing, the actual lineage cannot be confirmed No data.
This is common for many modern cannabis strains, especially those circulating outside regulated seed banks. Breeders often do not publish detailed cross information, and without independent testing (such as SNP or microsatellite analysis), claims about parent genetics are speculative. If you are interested in the actual genetic heritage, ask your seed vendor or breeder for documentation—most cannot provide it Anecdote.
Cannabinoids & Terpenes
Published laboratory analyses specific to Magic Knight are not available. Anecdotal grower reports suggest THC levels in the 15–20% range, with minor cannabinoids (CBD, CBG) typical for modern hybrids—under 1% Weak / limited.
Terpene profiles are similarly undocumented. Some users report a dominant terpene profile of myrcene or limonene, but without lab chromatography data, these are guesses based on smell and flavor Anecdote. Do not assume terpene content or ratio from aroma alone; different growing conditions, curing methods, and storage can dramatically alter volatile terpene concentrations [1].
If you obtain Magic Knight legally in a regulated market, check the lab report on the package. In unregulated or gray-market sources, you have no reliable information about its actual chemistry No data.
Reported Effects
No controlled clinical studies have tested Magic Knight's subjective or pharmacological effects. User reports and breeder marketing claim it produces effects ranging from relaxation to mild euphoria, typical of balanced hybrids, but individual response depends on many factors: dose, tolerance, setting, individual neurobiology, and actual cannabinoid/terpene content Anecdote.
The popular idea that 'strain name predicts effect' is folklore Disputed. Two samples labeled "Magic Knight" from different growers may contain different cannabinoid ratios, terpene profiles, and contaminants, and therefore produce different effects in the same person [1], [2].
Cannabinoid content (THC and CBD levels) correlates more reliably with acute effects than strain name does [2]. If you are seeking consistent effects, ask for lab-tested products with quantified THC and CBD, not strain name alone Strong evidence.
Cultivation
No published cultivation guide specific to Magic Knight exists. Grower reports suggest it is moderate difficulty, with a flowering time of 8–9 weeks and moderate indoor yields (estimated 1–1.5 oz/sq ft), but these figures are anecdotal and unverified Anecdote.
If you grow Magic Knight or any strain, expect variation based on:
- Phenotype: Different seeds from the same cross may flower faster or slower, and have different morphology Strong evidence.
- Conditions: Light intensity, temperature, humidity, nutrients, and CO₂ all affect yield and final cannabinoid profile Strong evidence.
- Grower skill: Pest management, pruning strategy, and harvest timing affect final product quality Anecdote.
If you purchased seeds, your seed vendor may provide more specific guidance. If not, follow general hybrid cultivation best practices: moderate feeding, stable environment (65–75°F during flower), and 9–10 weeks average flowering for hybrids Strong evidence.
Marketing vs. Reality
Magic Knight, like most cannabis strains, is sold on story and aesthetics rather than pharmacological data. Marketing claims often include:
- "Magical" or mystical effects: Unsubstantiated. The name is branding, not description Anecdote.
- Specific terpene profiles claimed to produce specific effects: Common folklore. While myrcene and limonene are real terpenes, the popular idea that a 0.5% threshold of myrcene makes a strain sedating is unsupported Disputed.
- Guaranteed yield or flowering time: Misleading. Actual results depend entirely on growing skill and conditions Anecdote.
- "Award-winning" or "elite" genetics: Many strains are labeled this way with no verifiable awards or breeding history Anecdote.
The honest take: Magic Knight is likely a competent hybrid, but you have no scientific evidence it is special. Choose based on lab-tested cannabinoid content, terpene data if available, and your own trial—not on strain reputation Strong evidence.
Sources
- Peer-reviewed Fischedick, J. T., Hazekamp, A., & Erkelens, T. (2010). The phytochemistry and bioactivity of Cannabis sativa L. Planta Medica, 76(14), 1468–1479.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Jin, D., Jin, S., & Gu, Y. (2020). Classification of Cannabis sativa L. chemotypes based on cannabinoid profile data. Plants, 9(11), 1506.
- Peer-reviewed Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Government U.S. Food and Drug Administration (2020). FDA and cannabis: Research and product approval issues. Center for Drug Evaluation and Research.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.